Immunology and Microbiology
Chronic Fatigue Syndrome
100%
Human Herpesvirus 6
47%
Allele
31%
Microbiome
31%
Human Herpesvirus 7
25%
Zoonotic
23%
Human Leukocyte Antigen
21%
Coinfection
21%
Myelopid
21%
Blood Plasma
20%
Tumor Necrosis Factor
19%
Microflora
19%
Legionella
17%
Cytokine
16%
Viral Load
16%
Prevalence
16%
Programmed Cell Death
16%
Human Parvovirus B19
15%
Human Immunodeficiency Virus
15%
Otitis Media
15%
Legionella pneumophila
15%
Autoimmunity
15%
Dirofilaria repens
15%
Tick-Borne Encephalitis
15%
Middle Ear
15%
Gut Microbiome
15%
Ulcerative Colitis
15%
Intestine Flora
13%
Interleukin 10
12%
Herpesviridae
12%
Interleukin 6
11%
Autoimmune Disease
11%
Gene Sequence
11%
ELISA
10%
Cell Death
10%
Seroprevalence
10%
Hepatitis C
9%
Zoonosis
9%
Immunoglobulin M Antibody
8%
Immunoglobulin G4
8%
Limb
8%
Blood Level
8%
Microorganism
8%
Autoantibodies
7%
Hepatitis Virus
7%
Enterobacteriaceae
7%
Seropositivity
7%
Macrophage Migration Inhibition Factor
7%
Fas Ligand
7%
Roseolovirus
7%
Medicine and Dentistry
Chronic Fatigue Syndrome
48%
Actinic Keratosis
30%
Pneumococcal Infection
30%
Plasminogen Activator Inhibitor-1
29%
Tick Borne Encephalitis
25%
Serotype
24%
Microbiome
23%
Clinical Feature
23%
Ulcerative Colitis
23%
Gut Microbiome
23%
Bleeding
19%
COVID-19
18%
Lyme Borreliosis
18%
Cross Sectional Study
16%
Mixed Infection
16%
Autoimmunity
15%
Liver Fibrosis
15%
Allele
15%
Human Immunodeficiency Virus
15%
Heart Surgery
15%
Sepsis
15%
RNA 16S
15%
Health Care Cost
13%
Pneumococcus
13%
Pneumococcal Pneumonia
11%
Streptococcus Pneumonia
11%
Biological Marker
11%
Outpatient
11%
Fibrinolysis
10%
Cardiopulmonary Bypass
8%
Programmed Cell Death
8%
Antibiotics
8%
Tick-Borne Disease
8%
Tympanic Cavity
8%
Differential Diagnosis
8%
Observational Study
8%
Disease Management
8%
Probiotics
8%
Tissue Plasminogen Activator
8%
Tick Bite
8%
Fibromyalgia
7%
Vancomycin
7%
Therapeutic Drug Monitoring
7%
Middle Ear
7%
General Medicine
7%
Enterobacteriaceae
7%
Myelopid
7%
P16
7%
Basal-Cell Carcinoma
7%
Diphtheria
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
38%
Vancomycin
37%
Therapeutic Drug Monitoring
33%
Chronic Fatigue Syndrome
26%
Sepsis
25%
Mixed Infection
23%
Colistimethate
23%
Actinic Keratosis
23%
HIV
23%
Cross-Sectional Study
18%
Prevalence
18%
Microbiome
17%
Liver Fibrosis
17%
Coronavirinae
16%
Antimicrobial Resistance
16%
Microflora
15%
Tick Borne Encephalitis
15%
Plasminogen Activator Inhibitor 1
15%
Clinical Feature
15%
Pneumococcal Infection
15%
Squamous Cell Carcinoma
11%
Cytokeratin 18
11%
Biological Marker
10%
Antibiotics
9%
Hepatitis C
9%
Virus Hepatitis
9%
Inflammatory Bowel Disease
8%
Hyaluronic Acid
8%
COVID-19 Vaccine
7%
Penicillinase
7%
Bowen's Disease
7%
Cyclin D
7%
Tumor Necrosis Factor
7%
Chronic Allograft Nephropathy
7%
Chronic Obstructive Lung Disease
7%
Dipeptidyl Carboxypeptidase
7%
Angiogenic Factor
7%
Wet Macular Degeneration
7%
Fas Ligand
7%
Macrophage Migration Inhibition Factor
7%
Adult Respiratory Distress Syndrome
7%
Legionella
7%
Amoeba (Life Cycle Stage)
7%
Case Fatality Rate
7%
Liver Abscess
7%
Enterococcus
7%
Disease Activity
7%
Interleukin 6
7%
Intercellular Adhesion Molecule 1
7%
MedDRA
7%
